Medical Journals

Comparative Genome Analysis Identifies the Vitamin D Receptor Gene As a Direct Target of P53-mediated Transcriptional Activation.

Authors:
  • Maruyama Reo
  • Aoki Fumio
  • Toyota Minoru
  • Sasaki Yasushi
  • Akashi Hirofumi
  • Mita Hiroaki
  • Suzuki Hiromu
  • Akino Kimishige
  • Ohe-Toyota Mutsumi
  • Maruyama Yumiko
  • Tatsumi Haruyuki
  • Imai Kohzoh
  • Shinomura Yasuhisa
  • Tokino Takashi

From: First Department of Internal Medicine, Sapporo Medical University, Sapporo, Japan.

Cancer research

  • Publish Date: May 2006
  • ISSN: 0008-5472
  • Volume: 66
  • Issue: 9
  • Pages: 4574-83
  • Medium: Print
  • Language: English
  • Citation (JAMA): Maruyama Reo, Aoki Fumio, Toyota Minoru, et al. Comparative Genome Analysis Identifies the Vitamin D Receptor Gene As a Direct Target of P53-mediated Transcriptional Activation.. Cancer Res. May 2006;66:4574-83

Abstract

p53 is the most frequently mutated tumor suppressor gene in human neoplasia and encodes a transcriptional coactivator. Identification of p53 target genes is therefore key to understanding the role of p53 in tumorigenesis. To identify novel p53 target genes, we first used a comparative genomics approach to identify p53 binding sequences conserved in the human and mouse genome. We hypothesized that potential p53 binding sequences that are conserved are more likely to be functional. Using stringent filtering procedures, 32 genes were newly identified as putative p53 targets, and their responsiveness to p53 in human cancer cells was confirmed by reverse transcription-PCR and real-time PCR. Among them, we focused on the vitamin D receptor (VDR) gene because vitamin D3 has recently been used for chemoprevention of human tumors. VDR is induced by p53 as well as several other p53 family members, and analysis of chromatin immunoprecipitation showed that p53 protein binds to conserved intronic sequences of the VDR gene in vivo. Introduction of VDR into cells resulted in induction of several genes known to be p53 targets and suppression of colorectal cancer cell growth. In addition, p53 induced VDR target genes in a vitamin D3-dependent manner. Our in silico approach is a powerful method for identification of functional p53 binding sites and p53 target genes that are conserved among humans and other organisms and for further understanding the function of p53 in tumorigenesis.

Mesh Headings (Keywords): Animals, Base Sequence, Binding Sites, Cell Line, Tumor, Cholecalciferol, Consensus Sequence, Gene Expression Regulation, Gene Targeting, Genes, p53, Genome, Human, HCT116 Cells, Humans, Mice, Molecular Sequence Data, Receptors, Calcitriol, Trans-Activation (Genetics), Transfection, Up-Regulation


Check for Full Text / PubMed Unique Identifier (PMID): 16651407


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.